SCHEMBL29587740

SCHEMBL29587740

Cc1cc(C(C)C)c(O)cc1Cl

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.84
TRPA1 O75762 2/20 0.47
CHRM1 P11229 1/20 0.47
SLC6A2 P23975 1/20 0.47
ADRA1A P35348 1/20 0.47
HTR2B P41595 1/20 0.47
GABRA1 P14867 2/20 0.45
GABRB1 P18505 1/20 0.45
ALDH1A1 P00352 4/20 0.44
POLB P06746 1/20 0.43
PKM P14618 2/20 0.41
GAA P10253 3/20 0.41
KDM4E B2RXH2 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP1A2 P05177 4/20 0.40
CYP2D6 P10635 3/20 0.40
MAPK1 P28482 1/20 0.40
ALOX15 P16050 3/20 0.39
ALOX12 P18054 1/20 0.39
CYP3A4 P08684 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5532293 1.00 LMNA (0.84) LMNATRPA1CHRM1SLC6A2ADRA1A
Chlorothymol SCHEMBL159122 0.91 LMNA (1.00) LMNATRPA1CHRM1SLC6A2ADRA1A
Chlorothymol SCHEMBL29431017 0.91 LMNA (1.00) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL10702604 0.84 LMNA (0.72) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL25552477 0.81 LMNA (0.68) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL214157 0.81 LMNA (0.68) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL29872559 0.81 LMNA (0.68) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL12297358 0.79 LMNA (0.59) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL9556365 0.79 LMNA (0.65) LMNATRPA1CHRM1SLC6A2ADRA1A
SCHEMBL10013261 0.79 LMNA (0.59) LMNATRPA1CHRM1SLC6A2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11352330-B2 Phenoxymethyl derivatives HOFFMANN-LA ROCHE INC. (US) 2022-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352330-B2 Phenoxymethyl derivatives CNKSR1, RB1, RCOR1 LMNA 2843/4885TRPA1 3835/4885CHRM1 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.